NEW YORK (GenomeWeb News) – Bioinformatics services and consulting company Eagle Genomics plans to raise £1 million ($1.6 million) in new financing to support commercialization of its new cloud-based life sciences data analysis product and expansion of its staff.

Eagle Genomics CEO David Flanders told GenomeWeb Daily News today that the four-and a-half year-old firm, based at the Babraham Research Campus in Cambridge, UK, is looking to raise the equity from venture capital and angel investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.